Urinary osteocalcin is a useful marker for monitoring the effect of alendronate therapy

Clin Chem. 2005 Dec;51(12):2362-5. doi: 10.1373/clinchem.2005.055541.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alendronate / therapeutic use*
  • Biomarkers
  • Drug Monitoring / methods*
  • Female
  • Humans
  • Immunoassay
  • Middle Aged
  • Osteocalcin / urine*
  • Osteoporosis / drug therapy*
  • Osteoporosis / prevention & control
  • Osteoporosis / urine
  • Time Factors

Substances

  • Biomarkers
  • Osteocalcin
  • Alendronate